The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...

Genomenon, a leader in genomic intelligence, today announced a strategic partnership with UCB to accelerate awareness, diagnosis, and research for thymidine kinase 2 deficiency (TK2d).

Lowering cysteine levels may boost fat burning and trigger brown fat production, offering a new approach to weight loss and ...

Genomic psychiatry is reshaping how we treat bipolar disorder—using genes to predict lithium response and personalize mental ...

Discovery of CXCL12’s role in red blood cell development could revolutionize artificial blood production and help address ...

World Population Day 2025 reminds us that behind the 8 billion count are lives, challenges, and global trends demanding ...

An autonomous fabric electrochemical biosensor for efficient health monitoring - ...

Analysis of hydroxychloroquine dosage in hospitalized COVID-19 patients shows low-dose benefits and high-dose risks.

Yale School of Medicine (YSM) was awarded a $27.7 million grant from Aligning Research to Impact Autism (ARIA) to develop an interdisciplinary research project to investigate non-invasive functional ...

U.S. FDA grants Orphan Drug Designation to Adcentrx's ADRX-0405 STEAP1 ADC for the treatment of gastric cancer ...

According to FIU neuroscientist Marcelo Bigliassi, simple, controlled physical challenges can recalibrate how people perceive exertion and rewire how your brain perceives effort, making exercise feel ...

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced t ...